Midkine inhibits apoptosis via extracellular signal regulated kinase (ERK) activation in PC12 cells

K Owada1, N Sanjyo, T Kobayashi

  • 1Department of Neurology, Faculty of Medicine, Tokyo Medical and Dental Unviersity, Japan.

Insights

Midkine (MK) protects neuronal cells from apoptosis by activating the ERK pathway. This study clarifies the intracellular mechanisms underlying MK

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Midkine (MK) is a heparin-binding growth factor involved in neuronal development and survival.
  • The precise intracellular mechanisms of MK's neurotrophic actions remain unclear.

Purpose of the Study:

  • To investigate the intracellular signaling pathway activated by Midkine (MK).
  • To determine the role of the mitogen-activated protein kinase (MAPK) cascade in MK's neuroprotective effects.

Main Methods:

  • Established an apoptosis-induction system using the PC12 neuronal cell line.
  • Administered Midkine (MK) and PD98059 (a MAPKK inhibitor) to assess effects on apoptosis and ERK activation.

Main Results:

  • Midkine (MK) demonstrated dose-dependent rescue of PC12 cells from serum deprivation-induced apoptosis.
  • MK activated extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2).
  • Inhibition of ERK activation by PD98059 blocked MK's neuroprotective effect.

Conclusions:

  • Midkine (MK) exerts significant neuroprotective effects.
  • The ERK signaling pathway is crucial for mediating the neurotrophic actions of Midkine (MK).

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...